Abstract
Background
There are large differences in socio-economic growth within the region of South East Asia, leading to sharp contrasts in health-systems development between countries. This study compares breast cancer presentation and outcome between patients from a high income country (Singapore) and a middle income country (Malaysia) in South East Asia.
Methods
Within the Singapore Malaysia Breast Cancer Registry we identified all consecutive patients diagnosed with breast cancer between 1993 and 2007 at the National University Hospital in Singapore (high income country, n = 2,141) and the University of Malaya Medical Center in Kuala Lumpur, Malaysia (middle income country, n = 3,320). We compared demographics, tumor characteristics, treatment patterns, and survival between patients from both countries.
Results
In Malaysia, patients were less often diagnosed with in situ breast cancer (adjusted odds ratio [ORadj] 0.2; 95 % confidence interval [95 % CI] 0.1–0.3), more likely to be diagnosed with late stage (III and IV) disease (ORadj for stage III 1.6; 95 % CI 1.3–2.0; ORadj for stage IV 1.2; 95 % CI 1.1–1.4) as compared to patients from Singapore. Univariate analysis showed that Malaysian patients were at a 72 % increased risk of death as compared to Singaporeans. After adjusting for other prognostic factors, the risk decreased by only 5 % (ORadj 1.67, 95 % CI 1.44–1.92).
Conclusions
Differences in way of presentation (except stage and tumor size) and treatment of breast cancer patients from the two countries are small. The overall survival of breast cancer patients from Malaysia is much lower than that of Singaporean patients.
Similar content being viewed by others
References
Yip CH (2009) Breast cancer in Asia. Methods Mol Biol 471:51–64
Yip CH, Cazap E, Anderson BO et al (2011) Breast cancer management in middle-resource countries (MRCs): consensus statement from the Breast Health Global Initiative. Breast 20(Suppl 2):S12–S19
Ravdin PM, Cronin KA, Howlader N et al (2007) The decrease in breast-cancer incidence in 2003 in the United States. N Engl J Med 356:1670–1674
Wang PP, Cao Y (1996) Incidence trends of female breast cancer in Saskatchewan, 1932–1990. Breast Cancer Res Treat 37:197–207
Fontenoy AM, Leux C, Delacour-Billon S et al (2010) Recent trends in breast cancer incidence rates in the Loire-Atlantique, France: a decline since 2003. Cancer Epidemiol 34:238–243
Takiar R, Srivastav A (2008) Time trend in breast and cervix cancer of women in India—(1990–2003). Asian Pac J Cancer Prev 9:777–780
Medina VM, Laudico A, Mirasol-Lumague MR et al (2010) Cumulative incidence trends of selected cancer sites in a Philippine population from 1983 to 2002: a joinpoint analysis. Br J Cancer 102:1411–1414
Sim X, Ali RA, Wedren S et al (2006) Ethnic differences in the time trend of female breast cancer incidence: Singapore, 1968–2002. BMC Cancer 6:261
Seow A, Koh WP, Chia KS et al. (2004) Trends In Cancer Incidence In Singapore 1968–2002 Singapore Cancer Registry, Singapore
Hirabayashi Y, Zhang M (2009) Comparison of time trends in breast cancer incidence (1973–2002) in Asia, from cancer incidence in five continents, Vols IV–IX. Jpn J Clin Oncol 39:411–412
Ministry of Health http://www.moh.gov.sg/mohcorp/statistics.aspx?id=5524. Accessed July 2011
World Bank. Country Classification http://data.worldbank.org/country/singapore. Accessed July 2011
Department of Statistics Singapore http://www.singstat.gov.sg/stats/latestdata.html. Accessed July 2011
Lim M-K (2009) Health Care Reforms in Singapore: Six Countries, Six Reform Models: The Health Care Reform, World Scientific Publishing Co. Pte. Ltd
Malaysia. US Department of State (2010) http://www.state.gov/r/pa/ei/bgn/2777.htm
World Bank. Country classification. http://data.worldbank.org/country/malaysia. Accessed July 2011
Barraclough S (1997) The growth of corporate private hospitals in Malaysia: policy contradictions in health system pluralism. Int J Health Serv 27:643–659
Francis T (2009) Health care in Malaysia: the dynamics of provision, financing and access. In: Barraclough S (ed) Heng Leng Chee SB. Routledge, London
Newman LA, Mason J, Cote D et al (2002) African-American ethnicity, socioeconomic status, and breast cancer survival. Cancer 94:2844–2854
Kogevinas M Pearce N, Susser M et al., eds. (1997) Social Inequalities and Cancer. IARC Scientific Publications no. 138, Lyon, France
Webster TF, Hoffman K, Weinberg J et al (2008) Community- and individual-level socioeconomic status and breast cancer risk: multilevel modeling on Cape Cod, Massachusetts. Environ Health Perspect 116:1125–1129
Barbone F, Filiberti R, Franceschi S et al (1996) Socioeconomic status, migration and the risk of breast cancer in Italy. Int J Epidemiol 25:479–487
Ferlay J, Shin H-R, Bray F et al (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127:2893–2917
Singapore Cancer Registry Report (2010) Trends in cancer incidence in Singapore 1968–2007. http://www.nrdo.gov.sg/
Yip CH, Taib NA, Mohamed I (2006) Epidemiology of breast cancer in Malaysia. Asian Pac J Cancer Prev 7:369–374
Bouchardy C, Verkooijen HM, Fioretta G (2006) Social class is an important and independent prognostic factor of breast cancer mortality. Int J Cancer 119:1145–1151
Pathy NB, Yip CH, Taib NA et al (2011) Breast cancer in a multi-ethnic Asian setting: results from the Singapore-Malaysia Hospital-based breast cancer registry. Breast 20(Suppl 2):S75–S80
Lim SE, Back M, Quek E et al (2007) Clinical observations from a breast cancer registry in Asian women. World J Surg 31:1387–1392
Sant M, Allemani C, Capocaccia R et al (2003) Stage at diagnosis is a key explanation of differences in breast cancer survival across Europe. Int J Cancer 106:416–422
Gondos A, Bray F, Brewster DH et al (2008) Recent trends in cancer survival across Europe between 2000 and 2004: a model-based period analysis from 12 cancer registries. Eur J Cancer 44:1463–1475
Pineda MD, White E, Kristal AR et al (2001) Asian breast cancer survival in the US: a comparison between Asian immigrants, US-born Asian Americans and Caucasians. Int J Epidemiol 30:976–982
Moller H, Sandin F, Bray F et al (2010) Breast cancer survival in England, Norway and Sweden: a population-based comparison. Int J Cancer 127:2630–2638
Redaniel MT, Laudico A, Mirasol-Lumague MR et al (2010) Breast cancer survival in different country settings: comparisons between a Filipino resident population, Filipino-Americans and Caucasians. Breast 19:109–114
Li CI, Malone KE, Daling JR (2003) Differences in breast cancer stage, treatment, and survival by race and ethnicity. Arch Intern Med 163:49–56
Kamangar F, Dores GM, Anderson WF (2006) Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 24:2137–2150
Curado MP, Voti L, Sortino-Rachou AM (2009) Cancer registration data and quality indicators in low and middle income countries: their interpretation and potential use for the improvement of cancer care. Cancer Causes Control 20:751–756
Sankaranarayanan R, Swaminathan R, Brenner H et al (2009) Cancer survival in Africa, Asia, and Central America: a population-based study. Lancet Oncol 11:165–173
Dahlui M, Ramli S, Bulgiba AM (2011) Breast cancer prevention and control programs in Malaysia. Asian Pac J Cancer Prev 12:1631–1634
Eley JW, Hill HA, Chen VW et al (1994) Racial differences in survival from breast cancer. Results of the National Cancer Institute Black/White Cancer Survival Study. JAMA 272:947–954
Ooi SL, Martinez ME, Li CI (2011) Disparities in breast cancer characteristics and outcomes by race/ethnicity. Breast Cancer Res Treat 127:729–738
Schopper D, de Wolf C (2009) How effective are breast cancer screening programmes by mammography? Review of the current evidence. Eur J Cancer 45:1916–1923
Kuhl CK, Schrading S, Leutner CC et al (2005) Mammography, breast ultrasound, and magnetic resonance imaging for surveillance of women at high familial risk for breast cancer. J Clin Oncol 23:8469–8476
Kaffashian F, Godward S, Davies T et al (2003) Socioeconomic effects on breast cancer survival: proportion attributable to stage and morphology. Br J Cancer 89:1693–1696
Lee-Feldstein A, Anton-Culver H, Feldstein PJ (1994) Treatment differences and other prognostic factors related to breast cancer survival. Delivery systems and medical outcomes. JAMA 271:1163–1168
Early Breast Cancer Trialists’ Collaborative Group (2005) Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 365:1687–1717
Chong HY, Taib NA, Rampal S et al (2011) Treatment options for locally advanced breast cancer—experience in an Asian tertiary hospital. Asian Pac J Cancer Prev 11:913–917
Holmes MD, Chen WY, Feskanich D et al (2005) Physical activity and survival after breast cancer diagnosis. JAMA 293:2479–2486
Taib NA, Yip CH, Low WY (2011) Recognising symptoms of breast cancer as a reason for delayed presentation in Asian Women—the psycho-socio-cultural model for breast symptom appraisal: ppportunities for intervention. Asian Pac J Cancer Prev 12:1601–1608
Schonberg MA, Marcantonio ER, Li D et al (2009) Breast cancer among the oldest old: tumor characteristics, treatment choices, and survival. J Clin Oncol 28:2038–2045
Early Breast Cancer Trialists’ Collaborative Group (2011) Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials. Lancet 378:1707–1716
Nakul S, Mikael H, Zakir H et al (2011) Impact of older age on presentation, management and outcome of breast cancer in the multi-ethnic Asian population of Singapore. J Geriatric Oncol 2:50–57
Krell J, James CR, Shah D et al (2011) Human epidermal growth factor receptor 2-positive breast cancer relapsing post-adjuvant trastuzumab: pattern of recurrence, treatment and outcome. Clin Breast Cancer 11:153–160
Acknowledgments
The Malaysian data were supported by HIR Grant UM.C/HlR/MOHE/06 from the Ministry of Higher Education, Malaysia. Nirmala Bhoo-Pathy was funded by the European Union through a PhD fellowship grant (AsiaLink program MY/AsiaLink/044[128–713]). This work was funded by the NUS Initiative to Improve Health in Asia (NIHA) Grant. Official Project Number: NIHA-2011-1-001. The authors are grateful to Kimberley S. K. Chua, Senior Research Coordinator at the National University Hospital, Singapore, for her help in data collection and verification.
Conflict of interest
All authors indicate no potential conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Saxena, N., Hartman, M., Bhoo-Pathy, N. et al. Breast Cancer in South East Asia: Comparison of Presentation and Outcome Between a Middle Income and a High Income Country. World J Surg 36, 2838–2846 (2012). https://doi.org/10.1007/s00268-012-1746-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00268-012-1746-2